• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Introduction to 1,8-naphthyridin-2-ylmethanamine (CAS No. 885270-90-6)

1,8-naphthyridin-2-ylmethanamine, identified by its Chemical Abstracts Service (CAS) number 885270-90-6, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the naphthyridine class, a structurally intriguing scaffold known for its broad spectrum of biological activities. The naphthyridine core, characterized by a fused bicyclic system containing nitrogen atoms at the 1 and 8 positions, provides a privileged structure that enhances interactions with biological targets, making it a valuable building block in drug discovery.

The structure of 1,8-naphthyridin-2-ylmethanamine features a methanamine substituent at the 2-position of the naphthyridine ring. This substitution pattern introduces a reactive amine group, which can be further functionalized to explore diverse pharmacological profiles. The compound’s molecular formula and connectivity contribute to its unique electronic and steric properties, which are critical in determining its interaction with enzymes and receptors. Such structural features have positioned 1,8-naphthyridin-2-ylmethanamine as a promising candidate for developing novel therapeutic agents.

In recent years, there has been a surge in research focused on naphthyridine derivatives due to their demonstrated efficacy in various therapeutic areas. The biological activity of 1,8-naphthyridin-2-ylmethanamine has been extensively studied, particularly in the context of antimicrobial and anticancer applications. Preliminary in vitro studies suggest that this compound exhibits inhibitory effects on certain enzymes and pathways associated with microbial growth and cancer cell proliferation. These findings align with the broader pharmacological potential of naphthyridine-based molecules.

One of the most compelling aspects of 1,8-naphthyridin-2-ylmethanamine is its versatility as a chemical probe. Researchers have leveraged its scaffold to develop libraries of derivatives with tailored biological activities. For instance, modifications at the amine group or other positions on the naphthyridine ring have led to compounds with enhanced potency or selectivity against specific targets. This adaptability underscores the importance of 1,8-naphthyridin-2-ylmethanamine as a key intermediate in synthetic chemistry and drug development pipelines.

The synthesis of 1,8-naphthyridin-2-ylmethanamine involves multi-step organic transformations that highlight the ingenuity of modern synthetic methodologies. Key steps typically include cyclization reactions to form the naphthyridine core followed by functional group interconversions to introduce the methanamine moiety at the desired position. Advances in catalytic processes have enabled more efficient and sustainable routes to this compound, reducing waste and improving yields—a critical consideration in industrial-scale production.

From a medicinal chemistry perspective, the pharmacokinetic properties of 1,8-naphthyridin-2-ylmethanamine are under active investigation. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for optimizing its therapeutic potential. Computational modeling techniques have been employed to predict these properties before experimental validation, streamlining the drug discovery process. Such efforts are vital for translating promising preclinical findings into viable clinical candidates.

The role of computational chemistry in studying 1,8-naphthyridin-2-ylmethanamine cannot be overstated. Molecular docking simulations have revealed insights into how this compound interacts with biological targets such as kinases and DNA gyrase inhibitors. These interactions are often critical for therapeutic efficacy but can also influence side effects if not carefully managed. By integrating experimental data with computational predictions, researchers can refine their understanding of 1,8-naphthyridin-2-ylmethanamine’s mechanism of action, paving the way for more targeted drug design.

In conclusion, 1,8-naphthyridin-2-ylmethanamine (CAS No. 885270-90-6) represents a significant advancement in pharmaceutical research due to its structural versatility and biological promise. Its role as both a synthetic intermediate and a lead compound underscores its importance in modern drug discovery efforts. As research continues to uncover new applications for this compound and its derivatives, 1,8-naphthyridin-2-ylmethanamine is poised to remain at the forefront of medicinal chemistry innovation.

• 1023655-32-4(1H-pyrrolo[2,3-b]pyridin-6-ylmethanamine)
• 933691-76-0(1H-pyrrolo[2,3-b]pyridin-2-ylmethanamine)
• 1569-16-0(2-Methyl-1,8-naphthyridine)
• 287719-81-7(1,8-Naphthyridine-2-methanamine,N-methyl-(9CI))
• 1788054-88-5(1H-pyrrolo[2,3-b]pyridin-2-ylmethanamine hydrochloride)
• 935505-76-3(7H-pyrrolo[2,3-d]pyrimidin-4-ylmethanamine)
• 1378817-39-0(7H-pyrrolo[2,3-d]pyrimidin-4-ylmethanamine hydrochloride)
• 1179533-37-9(7-Methyl-1,8-naphthyridine-2-carboximidamide)
• 1179532-93-4(1,8-Naphthyridine-2-carboximidamide)
• 14903-78-7(2,7-dimethyl-1,8-Naphthyridine)